Amended Report of Foreign Issuer (6-k/a)
August 08 2017 - 5:25PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 6-K/A
REPORT OF
FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of
August 2017
Commission File Number:
001-31995
MEDICURE
INC.
(Translation of registrant's name into English)
2-1250 Waverley Street
Winnipeg, MB Canada R3T 6C6
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
o
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
o
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
o
Indicate by check mark whether the registrant
by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule
12g3-2(b) under the Securities Exchange Act of 1934.
Yes
o
No
x
If “Yes” is marked, indicate below
the file number assigned to the registrant in connection with Rule 12g3-2(b): 8a72____.
EXPLANATORY
NOTE
We are refiling a corrected version of
the c
ondensed consolidated interim financial statements of
Medicure Inc.
for
the three and six months ended June 30, 2017
(unaudited).
These replace the version filed on August
7, 2017. Pages 1 and 2 have been corrected to reflect the addition of $25,000 to the accounts payable and accrued liabilities line
on page 2, which was not included in the original filing as a result of an inadvertent error. This results in changes to the
subtotals and totals on pages 1 and 2. Other than to correct this omission, there are no other changes.
EXHIBIT
LIST
Exhibit
|
Title
|
99.1
|
Financial Statements
|
99.3
|
CEO Certification
|
99.4
|
CFO Certification
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Medicure Inc.
|
|
(Registrant)
|
|
|
|
|
|
Date: August 8, 2017
|
By:
|
/s/ Albert
D. Friesen
|
|
Albert D. Friesen
|
|
Chief Executive Officer
|
Medicure (PK) (USOTC:MCUJF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medicure (PK) (USOTC:MCUJF)
Historical Stock Chart
From Sep 2023 to Sep 2024